Literature DB >> 19416210

Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat.

Alsadek H Bogzil1, Nick Ashton.   

Abstract

Relaxin causes renal hyperfiltration, natriuresis, and diuresis in male rats. This study determined the effect of recombinant human relaxin (rhRLX) on renal function in the female rat. After 7 days of rhRLX treatment (0.4 microg/h) urinary excretion of sodium and chloride were significantly lower in the rhRLX-treated group, but urine flow rate was not different from that in controls. Quantitative PCR showed that the RXFP1 receptor was expressed in both the renal cortex and medulla; immuno-localization revealed expression in the proximal tubule and inner medullary collecting ducts. These data show that relaxin elicits pregnancy-like changes in renal function in the female rat.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416210     DOI: 10.1111/j.1749-6632.2008.03797.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

Authors:  Jennifer M Sasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 2.  Relaxin: review of biology and potential role in treating heart failure.

Authors:  Sam L Teichman; Elaine Unemori; John R Teerlink; Gad Cotter; Marco Metra
Journal:  Curr Heart Fail Rep       Date:  2010-06

3.  Antidiuretic effects of the endothelin receptor antagonist avosentan.

Authors:  Ovidiu Constantin Baltatu; Radu Iliescu; Christian E Zaugg; Jane F Reckelhoff; Pat Louie; Christoph Schumacher; Luciana Aparecida Campos
Journal:  Front Physiol       Date:  2012-04-18       Impact factor: 4.566

4.  Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.

Authors:  Licette C Y Liu; Adriaan A Voors; John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Yakuan Chen; Barry H Greenberg; Piotr Ponikowski; Peter S Pang; Margaret F Prescott; Tsushung A Hua; Thomas M Severin; Marco Metra
Journal:  Clin Res Cardiol       Date:  2016-03-26       Impact factor: 5.460

5.  H3 relaxin protects against calcium oxalate crystal-induced renal inflammatory pyroptosis.

Authors:  Jiannan Liu; Kelaier Yang; Yinshan Jin; Yadong Liu; Yaodong Chen; Xiaohui Zhang; Shiliang Yu; Erlin Song; Song Chen; Jingbo Zhang; Guanhua Jing; Ruihua An
Journal:  Cell Prolif       Date:  2020-09-18       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.